PPF Interest Rate Stays Firm at 7.1% for Oct-Dec 2025 Quarter: What You Need to Know!

October 3, 2025

PPF Interest Rate Stays Firm at 7.1% for Oct-Dec 2025 Quarter: What You Need to Know!

Great news for PPF investors! The Ministry of Finance has kept the Public Provident Fund interest rate steady at 7.1% for the October to December 2025 quarter. Learn how your savings grow, tax perks, and the rules on deposits and maturity in this easy guide.

Metal Stocks Shine Bright as Lloyds Metals Soars Over 6%; Sensex and Nifty Gain

October 3, 2025

Metal Stocks Shine Bright as Lloyds Metals Soars Over 6%; Sensex and Nifty Gain

Friday saw a sparkling rally in metal stocks with Lloyds Metals jumping 6.14%. Tata Steel, National Aluminium, and others followed, lifting the BSE metal index by 1.85%. The Sensex rose 223.86 points, boosted by optimism on a possible Fed rate cut and steady metal prices.

Maths Skills: The Secret Weapon to Unlock India's Skill India & Demographic Dividend

October 3, 2025

Maths Skills: The Secret Weapon to Unlock India's Skill India & Demographic Dividend

Math is not just a school subject—it’s a powerful work skill! Learn how India’s policies like NEP 2020 and Skill India use Maths to turn learners into job-ready stars. From carpenters to retail pros, Maths sharpens minds and boosts employability like never before!

Santhosh Narayanan Sparks New Music Revolution with India-Based Streaming Platform

October 3, 2025

Santhosh Narayanan Sparks New Music Revolution with India-Based Streaming Platform

Music maestro Santhosh Narayanan is building a super transparent and budget-friendly music streaming platform from India. This dream project will spotlight both legends and fresh stars, with top artist payouts and a call for young talent through exciting hackathons!

European Experts Say Novo Nordisk and Eli Lilly Weight-Loss Drugs Should Lead Obesity Fight!

October 3, 2025

European Experts Say Novo Nordisk and Eli Lilly Weight-Loss Drugs Should Lead Obesity Fight!

Europe’s top obesity experts shout out Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide as the best first medicines to fight obesity and its problems. These drugs, sold as Wegovy, Ozempic, Zepbound, and Mounjaro, are game changers. New guidelines reveal who should get what, making weight loss easier, safer, and smarter!